2nd International Symposium on Merkel Cell Carcinoma
Register Today for the 2nd International Symposium on Merkel Cell Carcinoma!
The UW Division of Dermatology is excited to host the 2nd International Symposium on Merkel Cell Carcinoma in Seattle, Wash, from April 25-26, 2022! This year's two-day symposium will be held in-person, and bring together thought leaders and active investigators in Merkel cell carcinoma (MCC) from around the world for the purpose of promoting scientific discourse and collaboration toward the goal of improved understanding of MCC biology, pathogenesis and therapy. The focus of this symposium is to explore emerging data that may allow improvements in clinical guidelines, develop innovative approaches, and to understand the basic biology that drives this disease. We will include updates from the most recent clinical guidelines as well as emerging data highlighting MCC biology.
The meeting will be presented in lecture format with talks from leaders in the field, as well junior faculty and trainees. We will also include focused panel discussions and poster presentations to optimize real time feedback and collaboration. The educational purpose of this symposium is to disseminate emerging data and to advance MCC research by stimulating collaborative meeting.
This program is designed for oncologists, dermatologists, pathologists, other healthcare professionals, and scientists interested in Merkel cell carcinoma.
Register to Attend
In-person attendance is currently sold out. Virtual attendance is still available. Registration closes April 20, 2022 at 5 p.m. PT.
*On-site registration will not be available.
Date & Location
Monday, April 25, 2022, 7 a.m. — Tuesday, April 26, 2022, 4 p.m.
4507 Brooklyn Avenue N.E.
Seattle, WA 98105
Agenda
View the agenda on the Continuing Medical Education website.
Continuing Medical Education (CME) Credit
CME credit will be available for trainees attending the live webinar in-person. Webinar registrants will receive instructions by email prior to the course. Learn More.
